Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study
Jain S, Anderson S, Steele J, Wilson H, Muniz J, Soslow J, Beroukhim R, Maksymiuk V, Jacquemyn X, Frosch O, Fonseca B, Harahsheh A, Buddhe S, Ashwath R, Thacker D, Maskatia S, Misra N, Su J, Siddiqui S, Vaiyani D, Vaikom-House A, Campbell M, Klein J, Huang S, Mathis C, Cornicelli M, Sharma M, Nagaraju L, Ang J, Uppu S, Ramachandran P, Patel J, Han F, Mandell J, Akam-Venkata J, DiLorenzo M, Brumund M, Bhatla P, Eshtehardi P, Mehta K, Glover K, Dove M, Aldawsari K, Kumar A, Barfuss S, Dorfman A, Minocha P, Yonts A, Schauer J, Cheng A, Robinson J, Powell Z, Srivastava S, Chelliah A, Sanil Y, Hernandez L, Gaur L, Antonchak M, Johnston M, Reich J, Nair N, Drugge E, Grosse-Wortmann L. Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study. EClinicalMedicine 2024, 76: 102809. PMID: 39290640, PMCID: PMC11406334, DOI: 10.1016/j.eclinm.2024.102809.Peer-Reviewed Original ResearchCOVID-19 vaccine-associated myocarditisLate gadolinium enhancementMid-term clinical outcomesVaccine-associated myocarditisCardiac magnetic resonanceMyocardial injuryMulticenter studyClinical diagnosis of acute myocarditisThird dose of mRNA vaccineDiagnosis of acute myocarditisDose of mRNA vaccinePresence of myocardial injuryNo cardiac deathsMedian follow-upCohort multicenter studyMultisystem inflammatory syndromeFollow-up informationCardiac manifestationsAcute myocarditisClinical courseInflammatory syndromeClinical presentationGadolinium enhancementCardiac dysfunctionThird dose
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply